2018
DOI: 10.1136/gutjnl-2018-317726
|View full text |Cite
|
Sign up to set email alerts
|

Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
172
0
3

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 214 publications
(190 citation statements)
references
References 10 publications
3
172
0
3
Order By: Relevance
“…Both BF-LPS and fragilysin can leak through the normally protective mucosal barriers of the GI-tract intestinal endothelium to induce substantial inflammatory pathology both systemically and after BBB transit into vulnerable CNS compartments, including the neocortical parenchyma of the brain (Fathi and Wu, 2016;Lukiw, 2016a,b;Zhao and Lukiw, 2018a,b;Barton et al, 2019;Batista et al, 2019;Fox et al, 2019;Sheppard et al, 2019;Zhao et al, 2019). Indeed, while Bacteroides fragilis is an anaerobic, Gram-negative, rod-shaped bacillus, and part of the normal microbiota of the human colon and is generally commensal, this microbe can cause a "smoldering" systemic infection if displaced into the bloodstream or surrounding tissue following disease, trauma or surgery (Hill et al, 2014a,b;Montagne et al, 2017;Tulkens et al, 2018;Erdo and Krajcsi, 2019;Fox et al, 2019;Patrick et al, 2019;Sarkar and Banerjee, 2019;Sweeney et al, 2019). When the highly toxic exudates of enterotoxigenic strains of B. fragilis escape the microbial-dense environment of the human GI-tract they can produce substantial systemic inflammatory pathology with significant mortality and morbidity.…”
Section: Gi-tract Exudates-bf-lps and Fragilysinmentioning
confidence: 99%
“…Both BF-LPS and fragilysin can leak through the normally protective mucosal barriers of the GI-tract intestinal endothelium to induce substantial inflammatory pathology both systemically and after BBB transit into vulnerable CNS compartments, including the neocortical parenchyma of the brain (Fathi and Wu, 2016;Lukiw, 2016a,b;Zhao and Lukiw, 2018a,b;Barton et al, 2019;Batista et al, 2019;Fox et al, 2019;Sheppard et al, 2019;Zhao et al, 2019). Indeed, while Bacteroides fragilis is an anaerobic, Gram-negative, rod-shaped bacillus, and part of the normal microbiota of the human colon and is generally commensal, this microbe can cause a "smoldering" systemic infection if displaced into the bloodstream or surrounding tissue following disease, trauma or surgery (Hill et al, 2014a,b;Montagne et al, 2017;Tulkens et al, 2018;Erdo and Krajcsi, 2019;Fox et al, 2019;Patrick et al, 2019;Sarkar and Banerjee, 2019;Sweeney et al, 2019). When the highly toxic exudates of enterotoxigenic strains of B. fragilis escape the microbial-dense environment of the human GI-tract they can produce substantial systemic inflammatory pathology with significant mortality and morbidity.…”
Section: Gi-tract Exudates-bf-lps and Fragilysinmentioning
confidence: 99%
“…[ 5 ] Additionally, the loss of intestinal barrier integrity directly affects the function of the intestinal barrier and results in the transportation of bacterial lipopolysaccharide (LPS) to the intestine, which activates a series of inflammatory reactions. [ 6 ] The consumption of HFD is reported to increase the intestinal abundance of Firmicutes . Some Firmicutes generate LPS that can convert bile acid into toxic deoxycholic acid (DCA).…”
Section: Introductionmentioning
confidence: 99%
“…A combination of size exclusion chromatography (SEC) and OptiPrep density gradient (DG) centrifugation was used to isolate EV from plasma. Sepharose CL-2B (GE Healthcare, Uppsala, Sweden, #17014001) was washed 3 times with PBS (Merck Millipore, Billerica, Massachusetts, USA) containing 0.32 % (w/v) trisodiumcitrate dihydrate (ChemCruz, Dallas, Texas, USA) 17 . For preparation of the SEC column, nylon filter with 20 µm pore size (Merck Millipore, Billerica, Massachusetts, USA) was placed on bottom of a 10 ml syringe (Romed, Wilnis, The Netherlands), followed by stacking of 10 ml Sepharose CL-2B.…”
Section: Methodsmentioning
confidence: 99%